India-US Trade Talks Advance Toward $500 Billion Goal Amid Ongoing Negotiations 
Israeli Airstrike in Northern Gaza Kills Five Palestinians Amid Fragile Ceasefire 
Trump Administration Proposes New Rule to Limit Joint Employer Liability 
Florida Governor Ron DeSantis Signs Law Restricting DEI Programs and Climate Initiatives 
Trump Administration Considers Expanding Refugee Program for White South Africans 
Trump Plans to Invite Putin to G20 Summit in Miami, Report Says 
Taiwan Coast Guard Conducts Rare Drill on Disputed South China Sea Island 
U.S. Intercepts Iranian Oil Tankers in Asian Waters Amid Rising Global Energy Crisis 
Zelensky Warns Ukraine Could Face Patriot Missile Supply Risks Amid Prolonged Iran Conflict 
Argentina Proposes Electoral Reform to Cut Costs and End Mandatory Primaries 
Trump Administration Launches Civil Rights Probe into NYC Education Department Over Pro-Palestinian Educators 
U.S. Criticizes Airspace Denials to Taiwan President as China Influence Grows 
Lebanon-Israel Ceasefire Extended as U.S. Pushes for Peace Talks 
U.S. Allows Iran Players in 2026 World Cup but Bars IRGC-Linked Individuals 
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work 
U.S. Army Soldier Charged in $400K Insider Betting Scheme on Maduro Capture 
Judge Orders Release of Family After Longest ICE Detention Under Trump Administration 
U.S. President Donald Trump recently sparked renewed discussion around cannabidiol regulation after calling on Congress to modernize existing laws to allow broader access to “full-spectrum” CBD products. In a post shared on Truth Social, Trump emphasized the need for updated legislation that ensures Americans can benefit from the full range of hemp-derived compounds, not just isolated CBD.
Full-spectrum CBD refers to products that contain a variety of naturally occurring cannabinoids, terpenes, and other compounds found in the cannabis plant, including trace amounts of THC within federally legal limits. Advocates argue that these compounds work together in what is known as the “entourage effect,” potentially enhancing the therapeutic benefits of CBD for issues such as anxiety, chronic pain, inflammation, and sleep disorders.
Trump’s statement highlights a growing debate in the U.S. CBD market, where current regulations remain fragmented and often unclear. While the 2018 Farm Bill legalized hemp-derived CBD at the federal level, restrictions and inconsistencies continue to limit consumer access to certain formulations, particularly full-spectrum products. Industry leaders and stakeholders have long pushed for clearer guidelines to support innovation, ensure product safety, and expand market opportunities.
The call for reform also reflects increasing consumer demand for natural wellness solutions. The global CBD market has seen rapid growth, driven by rising awareness of its potential health benefits and shifting public perception of cannabis-related products. However, regulatory uncertainty has slowed progress in areas such as product labeling, quality control, and interstate commerce.
By urging Congress to revisit CBD legislation, Trump has added momentum to ongoing discussions about cannabis policy reform in the United States. Supporters believe that updated laws could strengthen the domestic hemp industry, create jobs, and provide consumers with safer, more effective CBD options. As lawmakers consider potential changes, the future of full-spectrum CBD products in the U.S. remains a closely watched issue for both businesses and consumers alike.
